Literature DB >> 20479293

Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man.

Supriya S Venugopal1, Dedee F Murrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20479293     DOI： 10.1001/archdermatol.2010.71

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  12 in total

1.  [Extragenital, disseminated infection with human papillomaviruses : Therapeutic response through vaccination with HPV].

Authors:  L Wiskemann; B Durani; W Hartschuh
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

2.  Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

Authors:  Richard Gilson; Diarmuid Nugent; Kate Bennett; Caroline J Doré; Macey L Murray; Jade Meadows; Lewis J Haddow; Charles Lacey; Frank Sandmann; Mark Jit; Kate Soldan; Michelle Tetlow; Emilia Caverly; Mayura Nathan; Andrew J Copas
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

3.  A novel modification of the autoimplantation therapy for the treatment of multiple, recurrent and palmoplantar warts.

Authors:  K C Nischal; C S Sowmya; M R Swaroop; Dhruv Premy Agrawal; H B Basavaraj; B D Sathyanarayana
Journal:  J Cutan Aesthet Surg       Date:  2012-01

4.  Nonavalent Human Papillomavirus Vaccination as a Treatment for Skin Warts in Immunosuppressed Adults: A Case Series.

Authors:  Simon Bossart; Valentina Imstepf; Robert E Hunger; S Morteza Seyed Jafari
Journal:  Acta Derm Venereol       Date:  2020-03-12       Impact factor: 3.875

Review 5.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

Review 6.  Evolving role of immunotherapy in the treatment of refractory warts.

Authors:  Devinder M Thappa; Minu J Chiramel
Journal:  Indian Dermatol Online J       Date:  2016 Sep-Oct

7.  Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult.

Authors:  Sara B Ferguson; Elisa S Gallo
Journal:  JAAD Case Rep       Date:  2017-07-26

8.  Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).

Authors:  Macey L Murray; Jade Meadows; Caroline J Doré; Andrew J Copas; Lewis J Haddow; Charles Lacey; Mark Jit; Kate Soldan; Kate Bennett; Michelle Tetlow; Mayura Nathan; Richard Gilson
Journal:  BMC Med Res Methodol       Date:  2018-11-06       Impact factor: 4.615

9.  Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study.

Authors:  Hoon Choi
Journal:  Int Braz J Urol       Date:  2019 Mar-Apr       Impact factor: 3.050

10.  Resolution of novel human papillomavirus-induced warts after HPV vaccination.

Authors:  Steffi Silling; Ulrike Wieland; Marko Werner; Herbert Pfister; Anja Potthoff; Alexander Kreuter
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.